BENDROFLUMETHIAZIDE: 1,009 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
1,009
Total FAERS Reports
4 (0.4%)
Deaths Reported
780
Hospitalizations
1,009
As Primary/Secondary Suspect
80
Life-Threatening
34
Disabilities
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
FDA Application: 012164 ·
First Report: 1972 · Latest Report: 20250203
What Are the Most Common BENDROFLUMETHIAZIDE Side Effects?
#1 Most Reported
Hyponatraemia
332 reports (32.9%)
#2 Most Reported
Acute kidney injury
192 reports (19.0%)
#3 Most Reported
Confusional state
127 reports (12.6%)
All BENDROFLUMETHIAZIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hyponatraemia | 332 | 32.9% | 0 | 317 |
| Acute kidney injury | 192 | 19.0% | 0 | 186 |
| Confusional state | 127 | 12.6% | 1 | 90 |
| Hypotension | 101 | 10.0% | 1 | 100 |
| Vomiting | 71 | 7.0% | 1 | 68 |
| Dizziness | 64 | 6.3% | 1 | 60 |
| Hypokalaemia | 64 | 6.3% | 1 | 59 |
| Fall | 60 | 6.0% | 0 | 60 |
| Malaise | 58 | 5.8% | 0 | 40 |
| Agitation | 57 | 5.7% | 0 | 22 |
| Pyrexia | 57 | 5.7% | 0 | 57 |
| Hallucination | 54 | 5.4% | 0 | 12 |
| Nausea | 53 | 5.3% | 1 | 45 |
| Orthostatic hypotension | 52 | 5.2% | 0 | 52 |
| Diarrhoea | 50 | 5.0% | 0 | 39 |
| Drug interaction | 46 | 4.6% | 0 | 35 |
| Pneumonia | 40 | 4.0% | 0 | 38 |
| Seizure | 40 | 4.0% | 0 | 36 |
| Dehydration | 39 | 3.9% | 0 | 38 |
| Off label use | 38 | 3.8% | 0 | 3 |
Who Reports BENDROFLUMETHIAZIDE Side Effects? Age & Gender Data
Gender: 64.4% female, 35.6% male. Average age: 72.8 years. Most reports from: GB. View detailed demographics →
Is BENDROFLUMETHIAZIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 8 | 0 | 0 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 0 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 1 |
| 2006 | 3 | 0 | 0 |
| 2007 | 4 | 0 | 4 |
| 2008 | 18 | 0 | 18 |
| 2009 | 2 | 0 | 1 |
| 2010 | 2 | 0 | 1 |
| 2011 | 33 | 0 | 33 |
| 2012 | 8 | 0 | 7 |
| 2013 | 23 | 0 | 11 |
| 2014 | 79 | 1 | 33 |
| 2015 | 72 | 0 | 68 |
| 2016 | 42 | 0 | 41 |
| 2017 | 113 | 1 | 74 |
| 2018 | 59 | 0 | 56 |
| 2019 | 92 | 0 | 92 |
| 2020 | 24 | 0 | 17 |
| 2021 | 7 | 0 | 2 |
| 2022 | 10 | 0 | 2 |
| 2023 | 10 | 0 | 9 |
| 2024 | 17 | 0 | 8 |
| 2025 | 4 | 0 | 4 |
What Is BENDROFLUMETHIAZIDE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 488 |
| Hypertension | 202 |
| Essential hypertension | 49 |
| Diuretic therapy | 16 |
| Blood pressure measurement | 15 |
| Ill-defined disorder | 8 |
| Nephrogenic diabetes insipidus | 6 |
| Oedema peripheral | 5 |
| Right ventricular failure | 5 |
BENDROFLUMETHIAZIDE vs Alternatives: Which Is Safer?
BENDROFLUMETHIAZIDE vs BENIDIPINE
BENDROFLUMETHIAZIDE vs BENLYSTA
BENDROFLUMETHIAZIDE vs BENRALIZUMAB
BENDROFLUMETHIAZIDE vs BENSERAZIDE
BENDROFLUMETHIAZIDE vs BENSERAZIDE\LEVODOPA
BENDROFLUMETHIAZIDE vs BENZALKONIUM
BENDROFLUMETHIAZIDE vs BENZOCAINE
BENDROFLUMETHIAZIDE vs BENZODIAZEPINE
BENDROFLUMETHIAZIDE vs BENZONATATE
BENDROFLUMETHIAZIDE vs BENZOYL PEROXIDE
Official FDA Label for BENDROFLUMETHIAZIDE
Official prescribing information from the FDA-approved drug label.